Mark: Not only it trades below book it trades at deep discount to cash on hand, and cash on hand is sufficient for about 3 years burn rate. Yet, the proof will be in the pudding, is oral tolerance a valid approach to combat autoimmune diseases. It could be dead money until they use up all their cash, and then become lost money.
And to the last poster, yes, technical analysis kept me out of the disaster, I was in at around 8 got out at around ten and then it had its meteoric rise (which my technicals missed), but I got back in just at two few weeks back and am happy to own it under cash on hand. By the way, the same technical analysis kept me out oof the disaster in IMMU and the big decline last year in IPIC. Unfortunately, it does not work all the time, and in most cases, one stays in despite technical analysis because of some excuses such as "fundamentally, it is a sound investment, for instance, our good old friend AKSEF.
Zeev |
